Success Metrics

Clinical Success Rate

88.9%

Based on 56 completed trials

Completion Rate

89%(56/63)

Active Trials

2(2%)

Results Posted

73%(41 trials)

Terminated

7(8%)

Phase Distribution

Ph phase_3

13%

Ph phase_2

40%

Ph not_applicable

19%

Ph early_phase_1

Ph phase_4

16%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution85 total trials

Early Phase 1First-in-human

8(9.4%)

Phase 1Safety & dosage

2(2.4%)

Phase 2Efficacy & side effects

34(40.0%)

Phase 3Large-scale testing

11(12.9%)

Phase 4Post-market surveillance

14(16.5%)

N/ANon-phased studies

16(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.7%

56 of 73 finished

Non-Completion Rate

23.3%

17 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(56)

Terminated(17)

Other(10)

Detailed Status

Completed56

Withdrawn10

unknown10

Terminated7

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

88.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 18 (9.4%)

Phase 12 (2.4%)

Phase 234 (40.0%)

Phase 311 (12.9%)

Phase 414 (16.5%)

N/A16 (18.8%)

Trials by Status

withdrawn1012%

active_not_recruiting11%

terminated78%

completed5666%

recruiting11%

unknown1012%

Recent Activity

2 active trials

Showing 5 of 85

terminatedphase_2

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

NCT05994703

active_not_recruitingphase_2

D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)

NCT05591677

View all 85 trials

Clinical Trials (85)

Showing 20 of 85 trialsScroll for more

NCT03535688Phase 2

D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain

Terminated

NCT07542548Phase 4

D-Cycloserine for Serine Palmitoyltransferase Inhibition

Completed

NCT03780829Early Phase 1

AIH for Spinal Cord Repair

Terminated

NCT05994703Phase 2

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

Completed

NCT05591677Phase 2

D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)

Active Not Recruiting

NCT05395494Phase 2

iTBS-DCS in Fibromyalgia

Terminated

NCT06121284Phase 2

iTBS+D-Cycloserine for Youth Suicide

Recruiting

NCT01450306Not Applicable

Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics

Completed

NCT05177601Phase 2

iTBS-DCS in Obsessive Compulsive Disorder

Unknown

NCT05731323Phase 1

D-Cycloserine+iTBS PK Study

Completed

NCT02385266Phase 4

Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain

Terminated

NCT04357951Early Phase 1

D-cycloserine Augmented Treatment for Youth With Tic Disorders

Withdrawn

NCT03216356Phase 2

Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

Withdrawn

NCT01512316Not Applicable

Exploring Learning and Unlearning of Fear

Withdrawn

NCT04762836Not Applicable

Pain, Learning, and Nocebo

Completed

NCT03937596Phase 2

Adjunctive D-Cycloserine in Major Depressive Disorder

Completed

NCT02635893Phase 4

Lower Limb Function After Spinal Cord Injury

Completed

NCT01944423Early Phase 1

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine

Completed

NCT01361633Phase 2

The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly

Completed

NCT04035603Phase 2

Multimodal Cue Exposure Therapy for Smoking Cessation

Withdrawn

Drug Details

Intervention Type: DRUG
Total Trials: 85